SCHEMBL19008922

SCHEMBL19008922

CC1(C)c2ccccc2-c2cnc(-c3cccc(-c4cc(-c5ccccc5)cc(-c5ccccc5)n4)c3)nc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PDK2 Q15119 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ IRAK1 P51617 2/20 0.32
▸ LTB4R Q15722 3/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ GABRA3 P34903 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19008900 0.95 PDK2 (0.36) CYP19A1MEN1KMT2AALDH1A1MAPT
SCHEMBL19008857 0.92 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL19008877 0.90 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL19008899 0.88 CYP19A1 (0.38) CYP19A1MEN1KMT2AALDH1A1MAPT
SCHEMBL19008905 0.88 CYP19A1 (0.36) CYP19A1MEN1KMT2APDK2SMN1; SMN2
SCHEMBL19008853 0.87 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL19008882 0.87 L3MBTL1 (0.36) KMT2AALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL19008908 0.86 CYP19A1 (0.35) CYP19A1MEN1KMT2AMAPTLMNA
SCHEMBL19008936 0.86 NPC1 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19008884 0.85 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10461262-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-29 — — US disclosed
US-20170179408-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed
US-20170179408-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10461262-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP19A1 61/4885MEN1 389/4885KMT2A 2042/4885
US-20170179408-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP19A1 61/4885MEN1 389/4885KMT2A 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback